HB923

HB923 expands the Texas Medical Disclosure Panel from nine to 13 members. The panel determines which medical and surgical risks must be disclosed to patients and the general form of those disclosures. Its new membership is:

• Seven Texas-licensed physicians.
• Three Texas-licensed lawyers, including at least one with experience representing patients and at least one with experience representing physicians or other health care providers.
• Three public members, at least one with a health-literacy background—experience with people’s ability to understand health information.

The Health and Human Services Commission’s executive commissioner appoints the members. HB923 updates the statute’s administrative and staffing references to HHSC while preserving the panel’s own responsibility for its substantive duties. Final law · Panel’s existing role

Public-member seats cannot go to registered lobbyists, health care providers or their spouses, or people working in any health-care-related field, including health insurance. The appointing official must prefer people with public-interest advocacy experience.

The panel cannot take action requiring a vote unless a majority of its appointed physician members are attending when the vote occurs. This is an attendance requirement, not a requirement that a majority of physicians vote in favor of every proposal. Existing law permits specified remote meeting participation; HB923 does not replace that framework with an in-person-only rule.

The act expressly bars the panel from changing any physician’s or health care provider’s scope of practice—the services that professional is legally authorized to perform. It took effect September 1, 2025, with new appointments required by January 1, 2026. Those are statutory requirements, not confirmation here of the current roster. Official history